200050-59-5
| 中文名称 | 200050-59-5 |
|---|---|
| 中文同义词 | 化合物 T15688 |
| 英文名称 | L-771688 |
| 英文同义词 | L-771688;5-Pyrimidinecarboxylic acid, 6-(3,4-difluorophenyl)-1,2,3,6-tetrahydro-4-(methoxymethyl)-2-oxo-1-[[[3-[4-(2-pyridinyl)-1-piperidinyl]propyl]amino]carbonyl]-, methyl ester, (6S)-;L771688,L 771688 |
| CAS号 | 200050-59-5 |
| 分子式 | C28H33F2N5O5 |
| 分子量 | 557.59 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 200050-59-5.mol |
| 结构式 |  |
200050-59-5 性质
| 密度 | 1.274±0.06 g/cm3(Predicted) |
|---|---|
| 储存条件 | Store at -20°C |
| 溶解度 | 溶于二甲基亚砜 |
| 酸度系数(pKa) | 10.90±0.70(Predicted) |
Ki: 0.43±0.02 nM (α1A-Adrenoceptor)
Specific [ 3 H]L-771688 binding to cloned human α1A-Adrenoceptors is inhibited with high potency by subtype selective compounds, GG818 (K i =0.026±0.002 nM) and L-771688 (K i =0.052±0.008 nM) and subtype non-selective α1-adrenoceptor antagonists, prazosin (K i =0.088±0.0.032 nM) and terazosin (K i =1.8±0.65 nM). The relative amount of [ 3 H]L-771688 (0.5 nM) binding in various rat tissue membranes is highest in submaxillary gland (9.5 pmol/g tissue), followed by brain (5.8 pmol/g tissue), vas deferens (4.3 pmol/g tissue), kidney (3.4 pmol/g tissue), heart (1.5 pmol/g tissue), urethra (1.1 pmol/g tissue) and prostate (0.88 pmol/g tissue). In contrast, low specific [ 3 H]L-771688 binding is observed in rat urinary bladder (0.55 pmol/g tissue), liver (0.44 pmol/g tissue), aorta (0.11 pmol/g tissue) and spleen (0.11 pmol/g tissue).